
Asset Management Ventures (AMV)
Description
Asset Management Ventures (AMV) is a venerable venture capital firm based in Palo Alto, California, with a rich history dating back to its founding in 1965. As one of the longest-standing venture capital firms, AMV has consistently focused on early-stage companies, primarily targeting Seed, Series A, and select Series B rounds. The firm prides itself on its deep roots in Silicon Valley and its commitment to fostering long-term partnerships with the entrepreneurs it backs.
AMV's investment strategy is centered on disruptive innovation within the digital health, life sciences, and technology sectors. They are known for their hands-on approach, leveraging their extensive network and operational expertise to support portfolio companies through critical growth phases. The firm's initial investments typically range from $500,000 to $5,000,000, reflecting their focus on providing crucial early capital to promising startups.
The firm's longevity in the venture capital landscape is a testament to its adaptive investment philosophy and its ability to identify and nurture groundbreaking companies across various technological cycles. AMV seeks out companies with strong management teams, defensible technology, and significant market potential, aiming to be a value-add partner beyond just capital provision. Their historical portfolio includes notable successes, underscoring their strategic acumen in these specialized fields.
Investor Profile
Asset Management Ventures (AMV) has backed more than 156 startups, with 4 new investments in the last 12 months alone. The firm has led 30 rounds, about 19% of its total and boasts 32 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Seed rounds (top funding stages).
- Majority of deals are located in United States, Ireland, Singapore.
- Strong thematic focus on Health Care, Biotechnology, Software.
- Typical check size: $500K – $5M.
Stage Focus
- Series A (21%)
- Series B (17%)
- Seed (16%)
- Series Unknown (15%)
- Series C (8%)
- Convertible Note (6%)
- Series D (5%)
- Debt Financing (3%)
- Private Equity (3%)
- Series F (3%)
Country Focus
- United States (95%)
- Ireland (3%)
- Singapore (1%)
- South Korea (1%)
- China (1%)
Industry Focus
- Health Care
- Biotechnology
- Software
- Medical
- Medical Device
- Pharmaceutical
- Mobile
- Health Diagnostics
- Saas
- Enterprise Software
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.